Investigation of rubella vaccine maked MICROGEN Federal State Company: study I trial
Experts of the RPU «Microgene», developed the new domestic medication for prevention of rubella — The rubella vaccine cultural live, on the basis of the vaccine strain RA 27/3. After the safety of vaccine had been proved on laboratory animals, the clinical trial had been activated on volunteers.The...
Saved in:
Main Authors: | A. N. Mironov, A. A. Tsaan, D. S. Bushmenkov, A. A. Romanova, Ye. S. Sidorenko, I. V. Feldblum |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2011-02-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/1316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toward Rubella and Congenital Rubella Syndrome Control and Elimination – Worldwide
by: article Editorial
Published: (2019-11-01) -
The State of Immunity of the Population of the Russian Federation to Rubella during the Elimination of Infection
by: L. A. Barkinkhoeva, et al.
Published: (2024-07-01) -
Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024
by: Anna Y. Popova, et al.
Published: (2025-06-01) -
Manifestations of the Epidemic Process of Measles and Rubella at the Present Stage
by: A. A. Pozdnyakov, et al.
Published: (2018-10-01) -
Features of laboratory tests for diagnosis of rubella in pregnant women
by: T. D. Grigor’eva, et al.
Published: (2014-10-01)